← Evidence map

ReviewDer Nervenarzt2020

[Ocrelizumab for treatment of multiple sclerosis].

Jonas Graf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32524163